LCMS webinars focusing on LC/MS - page 74

Optimizing SWATH-DIA for Exposomics and Metabolomics

Optimizing SWATH-DIA for Exposomics and Metabolomics

How to optimize your untargeted approaches on Zeno SWATH DIA using a modular workflow.
RECORD
|
Already taken place Tu, 14.11.2023
Technology Networks
tag
share
more
Optimizing SWATH-DIA for Exposomics and Metabolomics
Quantitative Excellence in Pharma & Biopharma

Quantitative Excellence in Pharma & Biopharma

Discover the ground-breaking technology that promises a whole new level of chromatographic performance in low-flow applications, making you rethink what's possible.
RECORD
|
Already taken place Tu, 14.11.2023
Thermo Fisher Scientific
tag
share
more
Quantitative Excellence in Pharma & Biopharma
Leveraging innovative stationary phase architectures and multi-detection strategies in biopharma and proteomics research to enhance precision, efficiency, and results

Leveraging innovative stationary phase architectures and multi-detection strategies in biopharma and proteomics research to enhance precision, efficiency, and results

The 1st key-note presentation will explore the pursuit of enhanced chromatographic performance in low-flow applications. The second part will take us to detection technologies.
RECORD
|
Already taken place Tu, 14.11.2023
Thermo Fisher Scientific
tag
share
more
Leveraging innovative stationary phase architectures and multi-detection strategies in biopharma and proteomics research to enhance precision, efficiency, and results
Pushing the boundaries of depth-of-coverage for nanoflow proteomics using Zeno SWATH DIA and IonOpticks Aurora SX series columns

Pushing the boundaries of depth-of-coverage for nanoflow proteomics using Zeno SWATH DIA and IonOpticks Aurora SX series columns

In this webinar, we will walk you through the use of Zeno SWATH DIA on the ZenoTOF 7600 system for high-performance proteomics analysis.
RECORD
|
Already taken place Su, 12.11.2023
SCIEX
tag
share
more
Pushing the boundaries of depth-of-coverage for nanoflow proteomics using Zeno SWATH DIA and IonOpticks Aurora SX series columns
Elevate efficiency: The power of automation

Elevate efficiency: The power of automation

Get started with a fast and efficient, automated sample preparation protocol on the Opentrons OT-2.
RECORD
|
Already taken place Th, 9.11.2023
Evosep Biosystems
tag
share
more
Elevate efficiency: The power of automation
SCIEX Biopharma meeting (Day 2) - Therapeutic proteins and peptides

SCIEX Biopharma meeting (Day 2) - Therapeutic proteins and peptides

Therapeutic proteins and peptides. The technologies presented will be CE and LC-MS.
RECORD
|
Already taken place We, 8.11.2023
SCIEX
tag
share
more
SCIEX Biopharma meeting (Day 2) - Therapeutic proteins and peptides
Intelligent LC/MS tools for quantitation and characterization of biopharmaceuticals

Intelligent LC/MS tools for quantitation and characterization of biopharmaceuticals

We will present end-to-end solutions for biopharma lab workflows with a focus on multiple mass spectrometry- based analysis techniques, ranging from SQ, TQ, TOF and Q-TOF.
RECORD
|
Already taken place Tu, 7.11.2023
Wiley
tag
share
more
Intelligent LC/MS tools for quantitation and characterization of biopharmaceuticals
SCIEX Biopharma meeting (Day 1) - Gene therapy, vaccines and oligonucleotides

SCIEX Biopharma meeting (Day 1) - Gene therapy, vaccines and oligonucleotides

Gene therapy, vaccines and oligonucleotides. The technologies presented will be CE and LC-MS.
RECORD
|
Already taken place Tu, 7.11.2023
SCIEX
tag
share
more
SCIEX Biopharma meeting (Day 1) - Gene therapy, vaccines and oligonucleotides
Biomarkers for liver cancer using N-Glycan MALDI Imaging

Biomarkers for liver cancer using N-Glycan MALDI Imaging

The principles of MALDI Imaging and how it is used to analyze N-linked glycans. Sample preparation and data acquisition techniques. Multiomic and multimodal data analysis strategies.
RECORD
|
Already taken place Th, 2.11.2023
Bruker
tag
share
more
Biomarkers for liver cancer using N-Glycan MALDI Imaging
Discover how Bristol-Myers Squibb uses electron-activated dissociation (EAD) to confidently identify drug metabolites and localize site of metabolism.

Discover how Bristol-Myers Squibb uses electron-activated dissociation (EAD) to confidently identify drug metabolites and localize site of metabolism.

Learn how EAD can be advantageous in confident identification and localization of drug metabolites.
RECORD
|
Already taken place Th, 2.11.2023
SCIEX
tag
share
more
Discover how Bristol-Myers Squibb uses electron-activated dissociation (EAD) to confidently identify drug metabolites and localize site of metabolism.
 

Related content

Microplastics and Nanomaterials: Understanding Emerging Contaminants in Environmental Testing

Microplastics and Nanomaterials: Understanding Emerging Contaminants in Environmental Testing

We, 8.4.2026
Organomation
Magnetic Bead-Based Protein Purification: A Faster and More Efficient Workflow

Magnetic Bead-Based Protein Purification: A Faster and More Efficient Workflow

We, 8.4.2026
Phenomenex
News from LabRulezLCMS Library - Week 15, 2026

News from LabRulezLCMS Library - Week 15, 2026

We, 8.4.2026
LabRulez
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike